TEGAFUR for Rectal cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where TEGAFUR was used for Rectal cancer.
Most Reported Side Effects for TEGAFUR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 26 | 13.3% | 2 | 5 |
| Disease progression | 24 | 12.2% | 6 | 3 |
| Myelosuppression | 24 | 12.2% | 0 | 6 |
| Vomiting | 24 | 12.2% | 5 | 4 |
| Diarrhoea | 22 | 11.2% | 5 | 8 |
| Decreased appetite | 19 | 9.7% | 2 | 7 |
| Anaemia | 18 | 9.2% | 3 | 3 |
| Fatigue | 16 | 8.2% | 2 | 5 |
| Neutropenia | 15 | 7.7% | 4 | 1 |
| Bone marrow failure | 14 | 7.1% | 0 | 5 |
| Thrombocytopenia | 13 | 6.6% | 2 | 4 |
| Death | 10 | 5.1% | 10 | 2 |
| Drug ineffective | 10 | 5.1% | 2 | 1 |
| Leukopenia | 10 | 5.1% | 0 | 1 |
| Alanine aminotransferase increased | 9 | 4.6% | 0 | 0 |
Other Indications for TEGAFUR
Gastric cancer (41)
Chemotherapy (11)
Colon cancer (11)
Product used for unknown indication (11)
Oesophageal carcinoma (9)
Adenocarcinoma (7)
Adenocarcinoma gastric (6)
Breast cancer (6)
Other Drugs Used for Rectal cancer
CAPECITABINE (2,976)
OXALIPLATIN (2,402)
FLUOROURACIL (1,610)
BEVACIZUMAB (1,546)
TIPIRACIL\TRIFLURIDINE (1,297)
IRINOTECAN (985)
LEUCOVORIN (660)
CETUXIMAB (542)
REGORAFENIB (505)
PANITUMUMAB (374)